Concomitant Gastric Malignancy and Hepatocellular Carcinoma

被引:0
|
作者
Mathew, Reshmi [1 ]
Churchill, Gregory [2 ]
Cheema, Bakht [2 ]
Desai, Ketav [3 ]
Alkhasawneh, Ahmad [3 ]
Liu, Shiguang [3 ]
Siddiqi, Anwer [3 ]
机构
[1] Univ Florida, Coll Med, Internal Med, Jacksonville, FL 32277 USA
[2] Univ Florida, Coll Med, Gastroenterol, Jacksonville, FL 32277 USA
[3] Univ Florida, Coll Med, Pathol, Jacksonville, FL 32277 USA
关键词
stomach ulcer; primary liver lesion; lymphoepithelioma-like carcinoma; epstein-barr virus; hepatitis c virus (hcv); multiple primary malignant neoplasm; hepatocellular carcinoma (hcc); gastric malignancy; CLINICAL ANALYSIS; VIRUS;
D O I
10.7759/cureus.25607
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Multiple primary malignant tumors (MPMTs) are two or more separate malignancies found at different sites concurrently. Prior studies have shown that the most common tumor associations in MPMTs are typically between two tumors in the digestive system. We present a case of a male patient in his 60s who initially presented with melena and was found to have a clean-based gastric ulcer on initial endoscopic evaluation. Repeat endoscopy on later admission revealed persistent ulceration. Biopsy showed Epstein-Barr virus (EBV) positive lymphoepithelioma-like gastric carcinoma (LELGC), a rare gastric malignancy. The patient underwent endoscopic ultrasound (EUS) for assessment of tumor depth and involvement of perigastric lymph nodes, but was incidentally found to have a liver lesion. Biopsy of the liver lesion was positive for hepatocellular carcinoma (HCC) with no morphologic similarity to the gastric malignancy. This case highlights a rare finding of MPMTs. In addition to the diagnosis of a rare gastric malignancy, the patient developed a well-known but uncommon phenomenon of non-cirrhotic HCC associated with hepatitis C virus (HCV). Due to an increasing number of advances in cancer therapy that are leading to increased survival times, clinicians can expect for a patient to develop MPMTs in their lifetime. A high index of suspicion must exist for the possibility of MPMTs because treatment options and outcomes can be vastly affected by their findings.
引用
收藏
页数:5
相关论文
共 50 条
  • [21] The safety and efficacy of peginterferon plus ribavirin in hepatitis C patients concomitant with malignancy other than hepatocellular carcinoma: a multicenter study
    Huang, Chung-Feng
    Huang, Jee-Fu
    Chen, Wu-Cheng
    Yeh, Ming-Lun
    Huang, Ching-I
    Yang, Jeng-Fu
    Chuang, Wan-Long
    Dai, Chia-Yen
    Hsieh, Ming-Yen
    Lin, Zu-Yau
    Chen, Shinn-Cherng
    Yu, Ming-Lung
    HEPATOLOGY INTERNATIONAL, 2013, 7 (01) : 180 - 187
  • [22] Concomitant hepatocellular carcinoma recurrence and mantle cell lymphoma
    Liang Xue
    Da-Long Wan
    Chen Hu
    Qing-Hong Ke
    Jie Zhou
    Yan Shen
    Hepatobiliary & Pancreatic Diseases International, 2024, (04) : 434 - 437
  • [23] Concomitant Hepatocellular Carcinoma and Gallbladder Adenocarcinoma: A Case Report
    Fenn, Kathleen
    Brejt, Sidney
    Liu, Farrah
    Hecht, Elizabeth
    Turk, Andrew
    Manji, Gulam
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2016, 111 : S911 - S911
  • [24] Surgical Resection for Hepatocellular Carcinoma with Concomitant Esophageal Varices
    Noboru Harada
    Ken Shirabe
    Takashi Maeda
    Hiroto Kayashima
    Teruyoshi Ishida
    Yoshihiko Maehara
    World Journal of Surgery, 2015, 39 : 2510 - 2518
  • [25] Risk factors of early re-bleeding and mortality in patients with ruptured gastric varices and concomitant hepatocellular carcinoma
    Chen-Jung Chang
    Ming-Chih Hou
    Wei-Chih Liao
    Fa-Yauh Lee
    Han-Chieh Lin
    Shou-Dong Lee
    Journal of Gastroenterology, 2012, 47 : 531 - 539
  • [26] Risk factors of early re-bleeding and mortality in patients with ruptured gastric varices and concomitant hepatocellular carcinoma
    Chang, Chen-Jung
    Hou, Ming-Chih
    Liao, Wei-Chih
    Lee, Fa-Yauh
    Lin, Han-Chieh
    Lee, Shou-Dong
    JOURNAL OF GASTROENTEROLOGY, 2012, 47 (05) : 531 - 539
  • [27] Expression of mucin 1 reflects the malignancy of hepatocellular carcinoma
    Yamazaki, Ken
    Masugi, Yohei
    Tsujikawa, Hanako
    Ojima, Hidenori
    Kitago, Minoru
    Shinoda, Masahiro
    Kitagawa, Yuko
    Sakamoto, Michiie
    CANCER SCIENCE, 2018, 109 : 718 - 718
  • [28] Early hepatocellular carcinoma as a signaling lesion for subsequent malignancy
    Midorikawa, Yutaka
    Takayama, Tadatoshi
    Higaki, Tokio
    Nakayama, Hisashi
    Yamamoto, Masakazu
    Ariizumi, Shunichi
    Shimada, Kazuaki
    Kokudo, Norihiro
    Tsuji, Shingo
    Tsuchiya, Kaoru
    Kurosaki, Masayuki
    Izumi, Namiki
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2016, 46 (12) : 1102 - 1107
  • [29] ORNITHINE DECARBOXYLASE AS AN INDEX OF MALIGNANCY IN HEPATOCELLULAR-CARCINOMA
    TAMORI, A
    NISHIGUCHI, S
    SEKI, S
    KUROKI, T
    KOBAYASHI, K
    OTANI, S
    KINOSHITA, H
    GASTROENTEROLOGY, 1993, 104 (04) : A1004 - A1004
  • [30] Imatinib inhibits the malignancy of hepatocellular carcinoma by suppressing autophagy
    Xiao, Meng-Chao
    Qian, Hui
    Huang, Chen-Kai
    Zheng, Bai-Nan
    Yan, Fang-Zhi
    Liu, Fang
    Zhang, Xin
    Chen, Shi-Jie
    Luo, Cheng
    Xie, Wei-Fen
    EUROPEAN JOURNAL OF PHARMACOLOGY, 2021, 906